EcoDrugPlus

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSAOCG00000005407
Gene Symbol: DHODH
3 Cross references
173 Possible Orthologues:

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSAOCG00000015840
Gene Symbol: DPYD
3 Cross references
217 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSAOCG00000017319
Gene Symbol: DDR2
3 Cross references
205 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSAOCG00000024751
Gene Symbol: DDR2
1 Cross references
189 Possible Orthologues:

Disintegrin And Metalloproteinase Domain-Containing Protein 17-Like

Ensembl ID : ENSAOCG00000009796
Gene Symbol: LOC111565930
3 Cross references
209 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSAOCG00000015856
Gene Symbol: DRD1
4 Cross references
188 Possible Orthologues:

Dopamine Receptor D1b

Ensembl ID : ENSAOCG00000001134
Gene Symbol: DRD1B
1 Cross references
200 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSAOCG00000006038
Gene Symbol: DRD2
3 Cross references
206 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSAOCG00000007050
Gene Symbol: DRD5
2 Cross references
164 Possible Orthologues:

Dual Specificity Mitogen-Activated Protein Kinase Kinase 2-Like

Ensembl ID : ENSAOCG00000015707
Gene Symbol: LOC111572311
3 Cross references
202 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSAOCG00000009410
Gene Symbol: ENPP2
3 Cross references
226 Possible Orthologues:

Egl Nine Homolog 2-Like

Ensembl ID : ENSAOCG00000014059
Gene Symbol: LOC111578698
2 Cross references
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).